Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size, Status and Forecast 2021-2027

体位性頻脈症候群(POTS)治療の世界市場規模・現状・予測2021年-2027年

◆タイトル:Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size, Status and Forecast 2021-2027
◆商品コード:QY21APR4716
◆調査・発行会社:QYResearch
◆発行日:2021年4月
◆ページ数:98
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、主要地域
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥429,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥643,500見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥858,000見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearchの日本における正規販売代理店です。

【レポートの概要】

本調査資料では、体位性頻脈症候群(POTS)治療の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(一次フォーム、二次フォーム)、用途別市場規模(病院、診療所、外来手術センター、研究所)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・体位性頻脈症候群(POTS)治療の市場動向
・企業の競争状況、市場シェア
・体位性頻脈症候群(POTS)治療の種類別市場規模(一次フォーム、二次フォーム)
・体位性頻脈症候群(POTS)治療の用途別市場規模(病院、診療所、外来手術センター、研究所)
・体位性頻脈症候群(POTS)治療の北米市場規模2016-2027(アメリカ、カナダ)
・体位性頻脈症候群(POTS)治療の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・体位性頻脈症候群(POTS)治療のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・体位性頻脈症候群(POTS)治療の中南米市場規模2016-2027(メキシコ、ブラジル)
・体位性頻脈症候群(POTS)治療の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Pfizer、Novartis、AstraZeneca、Merck、Sanofi、Daiichi Sankyo、Bayer)
・結論

Postural orthostatic tachycardia syndrome (POTS) is a condition in which a change from lying to standing causes an abnormally large increase in heart rate.
Postural orthostatic tachycardia syndrome treatment may include avoiding factors that bring on symptoms, increasing dietary salt and water, compression stockings, exercise, cognitive behavioral therapy and medications.

Market Analysis and Insights: Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market
The global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment market.

Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Scope and Market Size
Postural Orthostatic Tachycardia Syndrome (POTS) Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Primary Forms
Secondary Forms

Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Research Institutes

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
Novartis
AstraZeneca
Merck
Sanofi
Daiichi Sankyo
Bayer

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Primary Forms
1.2.3 Secondary Forms
1.3 Market by Application
1.3.1 Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Research Institutes
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Perspective (2016-2027)
2.2 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Growth Trends by Regions
2.2.1 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Industry Dynamic
2.3.1 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Trends
2.3.2 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Drivers
2.3.3 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Challenges
2.3.4 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Players by Revenue
3.1.1 Global Top Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Players by Revenue (2016-2021)
3.1.2 Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Revenue
3.4 Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Concentration Ratio
3.4.1 Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Revenue in 2020
3.5 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Key Players Head office and Area Served
3.6 Key Players Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Product Solution and Service
3.7 Date of Enter into Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Breakdown Data by Type
4.1 Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Historic Market Size by Type (2016-2021)
4.2 Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Forecasted Market Size by Type (2022-2027)

5 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Breakdown Data by Application
5.1 Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Historic Market Size by Application (2016-2021)
5.2 Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size (2016-2027)
6.2 North America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type
6.2.1 North America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2016-2021)
6.2.2 North America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2022-2027)
6.2.3 North America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2016-2027)
6.3 North America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application
6.3.1 North America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2016-2021)
6.3.2 North America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2022-2027)
6.3.3 North America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2016-2027)
6.4 North America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Country
6.4.1 North America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Country (2016-2021)
6.4.2 North America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size (2016-2027)
7.2 Europe Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type
7.2.1 Europe Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2016-2021)
7.2.2 Europe Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2022-2027)
7.2.3 Europe Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2016-2027)
7.3 Europe Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application
7.3.1 Europe Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2016-2021)
7.3.2 Europe Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2022-2027)
7.3.3 Europe Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2016-2027)
7.4 Europe Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Country
7.4.1 Europe Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Country (2016-2021)
7.4.2 Europe Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size (2016-2027)
8.2 Asia-Pacific Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type
8.2.1 Asia-Pacific Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application
8.3.1 Asia-Pacific Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Region
8.4.1 Asia-Pacific Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size (2016-2027)
9.2 Latin America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type
9.2.1 Latin America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2016-2027)
9.3 Latin America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application
9.3.1 Latin America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2016-2027)
9.4 Latin America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Country
9.4.1 Latin America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size (2016-2027)
10.2 Middle East & Africa Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type
10.2.1 Middle East & Africa Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application
10.3.1 Middle East & Africa Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Country
10.4.1 Middle East & Africa Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Introduction
11.1.4 Pfizer Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Introduction
11.2.4 Novartis Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Details
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Introduction
11.3.4 AstraZeneca Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2016-2021)
11.3.5 AstraZeneca Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Introduction
11.4.4 Merck Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2016-2021)
11.4.5 Merck Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Introduction
11.5.4 Sanofi Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2016-2021)
11.5.5 Sanofi Recent Development
11.6 Daiichi Sankyo
11.6.1 Daiichi Sankyo Company Details
11.6.2 Daiichi Sankyo Business Overview
11.6.3 Daiichi Sankyo Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Introduction
11.6.4 Daiichi Sankyo Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2016-2021)
11.6.5 Daiichi Sankyo Recent Development
11.7 Bayer
11.7.1 Bayer Company Details
11.7.2 Bayer Business Overview
11.7.3 Bayer Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Introduction
11.7.4 Bayer Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2016-2021)
11.7.5 Bayer Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Primary Forms
Table 3. Key Players of Secondary Forms
Table 4. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Regions (2016-2021)
Table 8. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Regions (2022-2027)
Table 10. Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Trends
Table 11. Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Drivers
Table 12. Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Challenges
Table 13. Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Restraints
Table 14. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Players (2016-2021)
Table 16. Global Top Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment as of 2020)
Table 17. Ranking of Global Top Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Product Solution and Service
Table 21. Date of Enter into Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Pfizer Company Details
Table 62. Pfizer Business Overview
Table 63. Pfizer Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Product
Table 64. Pfizer Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2016-2021) & (US$ Million)
Table 65. Pfizer Recent Development
Table 66. Novartis Company Details
Table 67. Novartis Business Overview
Table 68. Novartis Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Product
Table 69. Novartis Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2016-2021) & (US$ Million)
Table 70. Novartis Recent Development
Table 71. AstraZeneca Company Details
Table 72. AstraZeneca Business Overview
Table 73. AstraZeneca Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Product
Table 74. AstraZeneca Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2016-2021) & (US$ Million)
Table 75. AstraZeneca Recent Development
Table 76. Merck Company Details
Table 77. Merck Business Overview
Table 78. Merck Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Product
Table 79. Merck Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2016-2021) & (US$ Million)
Table 80. Merck Recent Development
Table 81. Sanofi Company Details
Table 82. Sanofi Business Overview
Table 83. Sanofi Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Product
Table 84. Sanofi Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2016-2021) & (US$ Million)
Table 85. Sanofi Recent Development
Table 86. Daiichi Sankyo Company Details
Table 87. Daiichi Sankyo Business Overview
Table 88. Daiichi Sankyo Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Product
Table 89. Daiichi Sankyo Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2016-2021) & (US$ Million)
Table 90. Daiichi Sankyo Recent Development
Table 91. Bayer Company Details
Table 92. Bayer Business Overview
Table 93. Bayer Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Product
Table 94. Bayer Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2016-2021) & (US$ Million)
Table 95. Bayer Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Type: 2020 VS 2027
Figure 2. Primary Forms Features
Figure 3. Secondary Forms Features
Figure 4. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Ambulatory Surgical Centers Case Studies
Figure 8. Research Institutes Case Studies
Figure 9. Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Report Years Considered
Figure 10. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Regions (2022-2027)
Figure 14. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Players in 2020
Figure 15. Global Top Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Revenue in 2020
Figure 17. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Type (2016-2027)
Figure 21. North America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Application (2016-2027)
Figure 22. North America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Country (2016-2027)
Figure 23. United States Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Type (2016-2027)
Figure 27. Europe Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Application (2016-2027)
Figure 28. Europe Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Country (2016-2027)
Figure 29. Germany Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Region (2016-2027)
Figure 39. China Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Pfizer Revenue Growth Rate in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2016-2021)
Figure 59. Novartis Revenue Growth Rate in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2016-2021)
Figure 60. AstraZeneca Revenue Growth Rate in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2016-2021)
Figure 61. Merck Revenue Growth Rate in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2016-2021)
Figure 62. Sanofi Revenue Growth Rate in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2016-2021)
Figure 63. Daiichi Sankyo Revenue Growth Rate in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2016-2021)
Figure 64. Bayer Revenue Growth Rate in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed


【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[体位性頻脈症候群(POTS)治療の世界市場規模・現状・予測2021年-2027年] (Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size, Status and Forecast 2021-2027 / QY21APR4716)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆